Neurochase
Phase 2Next Generation CNS Delivery Targeted Delivery of CNS Therapeutics Most current treatments only target the symptoms of many Neurological diseases but with gene therapies, for the first time, there may be an opportunity to cure many of these conditions. However, many promising treatments are failing clinical trials, not because of the drug itself but because
About
Next Generation CNS Delivery Targeted Delivery of CNS Therapeutics Most current treatments only target the symptoms of many Neurological diseases but with gene therapies, for the first time, there may be an opportunity to cure many of these conditions. However, many promising treatments are failing clinical trials, not because of the drug itself but because
Funding History
1Total raised: $1.8M
Company Info
Contact
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile